Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 200,317 | 107,667 | 91,641 | 102,827 | 111,597 |
| Marketable Securities | 552,923 | 463,699 | 521,546 | 374,543 | 201,410 |
| Other current assets | 14 | 0 | 102 | 102 | 102 |
| TOTAL | $767,357 | $581,664 | $626,818 | $486,478 | $323,839 |
| Non-Current Assets | |||||
| PPE Net | 1,290 | 1,514 | 1,526 | 1,672 | 1,800 |
| Other Non-Current Assets | 3,253 | 2,485 | 2,037 | 2,274 | 3,118 |
| TOTAL | $4,543 | $3,999 | $3,563 | $3,946 | $4,918 |
| Total Assets | $771,900 | $585,663 | $630,381 | $490,424 | $328,757 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,338 | 3,140 | 2,676 | 2,239 | 3,735 |
| Accrued Expenses | 34,738 | 30,370 | 23,163 | 24,108 | 19,224 |
| TOTAL | $41,364 | $36,762 | $26,127 | $26,635 | $23,247 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,523 | 17,487 | 20,328 | 20,205 | 20,000 |
| Deferred Revenues | 288 | 288 | 288 | 288 | 288 |
| Other Non-Current Liabilities | 2,161 | 1,648 | 896 | 989 | 1,289 |
| TOTAL | $23,040 | $19,563 | $21,724 | $21,767 | $21,934 |
| Total Liabilities | $64,404 | $56,325 | $47,851 | $48,402 | $45,181 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 79,213 | 63,890 | 63,822 | 62,768 | 52,586 |
| Common Shares | 792 | 639 | 638 | 540 | 437 |
| Retained earnings | -916,132 | -839,443 | -774,450 | -725,908 | -659,048 |
| Other shareholders' equity | 189,817 | 199,167 | 199,343 | 206,854 | 134,848 |
| TOTAL | $707,496 | $529,338 | $582,530 | $442,022 | $283,576 |
| Total Liabilities And Equity | $771,900 | $585,663 | $630,381 | $490,424 | $328,757 |